Founded in 1963, bioMérieux is a family-owned company that has become a global leader in the field of in vitro diagnostics. With a legacy rooted in scientific innovation and a deep commitment to public health, the company designs, develops, and manufactures cutting-edge diagnostic solutions that help healthcare professionals and industry players make critical decisions with confidence.

Present in 45 countries and serving clients in over 160, bioMérieux has built a robust international presence supported by an extensive distribution network. The company plays a crucial role in the detection and identification of pathogens, driving progress in medical diagnostics and contributing to improved patient outcomes and enhanced consumer safety.

Guided by a strong sense of purpose and independence, bioMérieux remains true to its heritage while continuously investing in innovation to meet the health challenges of today and tomorrow.